Skip to content
★ Sign in to follow
SA

Serodus ASA Stock: price and insider trades · Norway

Serodus ASA: what insiders have been doing

We have very little insider data for Serodus ASA so far: the most recent filing dates from 3 January 2017. With so few records, no pattern can be drawn yet. This summary is built from Oslo Børs disclosures alone and does not predict where the share price will go.

Insider Decl.
15
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€13,551
1 ops. · all time
Last declaration on 3 January 2017
Declarations15 total
  • ●
    Related company / holdingExecutives(filed)
    119,835 NOK0Oslo
    50,000 shares@ NOK 2.3967OptionXOAXOSLO:417212
  • ▼
    Executives(filed)
    123,335 NOK0Oslo
    39,971 shares@ NOK 3.0856OptionXOAXOSLO:414773
  • ●
    Related company / holdingExecutives(filed)
    97,270 NOK0Oslo
    84,583 shares@ NOK 1.15ShareXOAXOSLO:411247
  • ●
    Executives(filed)
    130,000 NOK0Oslo
    100,000 shares@ NOK 1.30OptionXOAXOSLO:405178
  • ●
    Related company / holdingExecutives(filed)
    268,688 NOK0Oslo
    125,000 shares@ NOK 2.1495ShareXOAXOSLO:391306
  • ●
    Executives(filed)
    0Oslo
    44,500 sharesOptionXOAXOSLO:385613
  • ●
    Executives(filed)
    0Oslo
    100,000 sharesShareXOAXOSLO:384942
  • ●
    Executives(filed)
    0Oslo
    44,500 sharesOptionXOAXOSLO:384814
  • ●
    Executives(filed)
    0Oslo
    50,000 sharesOptionXOAXOSLO:384807
  • ●
    Executives
    Executives(filed)
    0Oslo
  • ●
    Executives(filed)
    0Oslo
    100,000 sharesOptionXOAXOSLO:384557
  • ●
    Executives(filed)
    0Oslo
    749,015 sharesShareXOAXOSLO:384468
  • ●
    Executives(filed)
    0Oslo
    27,800 sharesOptionXOAXOSLO:384342
  • ●
    Related company / holdingExecutives(filed)
    0Oslo
    10,000 sharesShareXOAXOSLO:372198
  • ●
    Related company / holdingExecutives(filed)
    0Oslo
    45,898 sharesShareXOAXOSLO:371103

15 of 15 declarations

About Serodus ASA

Serodus ASA is a company listed on the XOSL market, focused on developing treatments for metabolic diseases. It aims to provide innovative solutions to enhance patient health.